Continuing education credit is not offered for these on-demand videos which are for informational purposes only. For courses offering continuing education, please checkout our live events or visit our partners at CASAT Learning.
By the end of the session, participants will be able to: Describe the ACE Study, its key findings, and the connection between ACEs and health outcomes, including substance use disorders. Explain how toxic stress impacts brain development, the body’s stress-response systems, and mental health, particularly as it relates to substance use risk factors. Identify the systemic issues that perpetuate cycles of trauma and substance use. Explore Positive Childhood Experiences (PCEs), protective factors, and evidence-based interventions that counteract ACEs and foster resilience.
Participate in a reflective exercise designed to strengthen internal resilience while establishing the foundation for the importance of Community Resiliency Model (CRM).
By the end of the session, participants will be able to:
- Outline the current state of the opioid crisis, and how it’s changed over time presenting unique challenges and opportunities.
- Recognize the need for substance use prevention and resilience.
- How a program with a mixed methods approach is changing how we view substance use prevention.
-Demonstrate how stories of loss can mobilize communities to make an impact.
As the opioid crisis continues to impact communities across the country, there is a growing need to strengthen the network of support around individuals with opioid use disorder (OUD). One critical role in this support system is the Community Health Worker (CHW). CHWs bridge gaps between healthcare, social and human service systems and individuals in need, offering culturally appropriate education, resources, and advocacy.
Over 80% of people with substance use disorders (SUDs), including opioid use disorder (OUD), smoke cigarettes. While smoking prevalence has decreased in the general population, it remains stubbornly high among people with opioid use disorder (OUD) and other substance use disorders (SUDs). Evidence suggests that conventional smoking cessation treatments are not as successful for people with SUDs as they are in the general population. This training will present the most recent epidemiology on smoking and use of cessation aids among people with SUDs, summarize the state of the science concerning smoking cessation treatment in this population, and present new data from Nevada on a smoking harm minimization intervention using e-cigarettes.
This online video will provide a comprehensive review of privacy and confidentiality laws relevant to opioid treatment providers. The session will cover federal and Nevada regulations, including HIPAA and 42 CFR Part 2, with a focus on practical applications and compliance challenges. The presentation will also explore emerging issues related to artificial intelligence and telehealth in opioid treatment settings. Participants will gain a clear understanding of confidentiality requirements, reporting obligations, and best practices for protecting patient privacy.
This Listening Session addresses the stigma surrounding Substance Use Disorder (SUD), and its impact on People Who Use Drugs (PWUD) communities receiving treatment, and exploring ways of fostering recovery-friendly spaces in the workplace and community.